New Key Statistics Module, Z-Score and F-Score
NAS:ZNTL Key Ratios
| Market Cap $ M | 223.99 |
| Enterprise Value $ M | 234.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.60 |
| Price/Sales | 5.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 40.00 |
| EPS (TTM) $ | -2.72 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -28.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.06 |
| EV-to-EBITDA | -1.07 |
| PEG | -- |
| Shares Outstanding M | 71.11 |
| Net Margin (%) | -479.92 |
| Operating Margin % | -543.77 |
| Pre-tax Margin (%) | -479.32 |
| Quick Ratio | 6.59 |
| Current Ratio | 6.59 |
| ROA % (ttm) | -34.66 |
| ROE % (ttm) | -42.62 |
| ROIC % (ttm) | -167.30 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.78 |
ZNTL Number of Guru Trades
ZNTL Volume of Guru Trades
Gurus Latest Trades with NAS:ZNTL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ZNTL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zentalis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ZNTL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers